Mark Ragosa, CHIEF FINANCIAL OFFICER at Kiniksa Pharmaceuticals International, plc (KNSA), sold 31,888 shares at $23.11 ($737K) on 2025-03-20, disclosed to the SEC on 2025-03-24.
Scheduled sale ($737k) by CHIEF FINANCIAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.11 | 15,944 | $368K | 50.0% |
| 2 | $23.11 | 15,944 | $368K | 50.0% |
| Total | $23.11 avg | 31,888 | $737K | 100% |
| Filing → |
| KNSA | SELL | 2026-01-09 | $503K | — | Filing → |
| KNSA | SELL | 2025-12-10 | $3.6M | — | Filing → |
| KNSA | SELL | 2025-11-14 | $815K | — | Filing → |